This is the authors' abstract. We don't add key points for this paper.
≈10% w/v), comparable to 10 µg/mL ascorbic acid, while HP-β-CD alone was inactive. Antibacterial assays using HP-β-CD/MHE showed concentration-dependent growth inhibition of Staphylococcus aureus and MRSA, but limited effect on Escherichia coli. ≥ 7.5% (w/v) inhibited all strains over 24 h. Furthermore, HP-β-CD/MHE attenuated the growth of gentamicin-resistant Acinetobacter baumannii and Enterococcus faecium by approximately 40% and 30%, respectively, relative to gentamicin-treated cultures, indicating activity against pathogens with reduced susceptibility to gentamicin. Biofilm formation by Staphylococcus aureus was inhibited by up to 100%. In co-culture, 10% HP-β-CD/MHE suppressed bacterial activity and maintained ∼ 92% stem-cell viability. These findings highlight improved dispersibility with retained bioactivity, supporting applications in alcohol-free antibacterial washes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: